Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all patients. Urologist Simon van Rij discusses the key considerations and options for personalised care, appropriate investigation and treatment
Gender-affirming hormone therapy also affected by ‘myths of E and P’
Gender-affirming hormone therapy also affected by ‘myths of E and P’
Sexual health specialist Massimo Giola discusses some common misunderstandings about the use of oestrogen and progestogen in transfeminine gender-diverse people
1. Nolan BJ, Frydman AS, Leemaqz SY, et al. Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study. Endocr Connect 2022;11(5):e220170.
2. Sudhakar D, Huang Z, Zietkowski M, et al. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks. Neurourol Urodyn 2023;42(5):903–20.
3. Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022;23(Suppl 1):S1–259.